152 related articles for article (PubMed ID: 37668669)
21. COVID-19 Disruptions to Endoscopic Surveillance in Lynch Syndrome.
McKenna DB; Dudzik CM; Kumar S; Mahmud N; Katona BW
Cancer Prev Res (Phila); 2021 May; 14(5):521-526. PubMed ID: 33627398
[TBL] [Abstract][Full Text] [Related]
22. Finding the needle in the haystack: the diagnostic accuracy of the faecal immunochemical test for colorectal cancer in younger symptomatic patients.
D'Souza N; Monahan K; Benton SC; Wilde L; Abulafi M;
Colorectal Dis; 2021 Oct; 23(10):2539-2549. PubMed ID: 34240526
[TBL] [Abstract][Full Text] [Related]
23. Patient attitudes towards faecal immunochemical testing for haemoglobin as an alternative to colonoscopic surveillance of groups at increased risk of colorectal cancer.
Bowyer HL; Vart G; Kralj-Hans I; Atkin W; Halloran SP; Seaman H; Wardle J; Wagner Cv
J Med Screen; 2013; 20(3):149-56. PubMed ID: 24045920
[TBL] [Abstract][Full Text] [Related]
24. Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round.
Digby J; Fraser CG; Carey FA; Diament RH; Balsitis M; Steele RJ
J Med Screen; 2017 Jun; 24(2):62-68. PubMed ID: 27370211
[TBL] [Abstract][Full Text] [Related]
25. An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test.
Rodríguez-Alonso L; Rodríguez-Moranta F; Ruiz-Cerulla A; Lobatón T; Arajol C; Binefa G; Moreno V; Guardiola J
Dig Liver Dis; 2015 Sep; 47(9):797-804. PubMed ID: 26055489
[TBL] [Abstract][Full Text] [Related]
26. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of a faecal immunochemical test in patients under colonoscopy surveillance of colorectal adenoma and cancer.
Olsson L; Sjöberg D
Ups J Med Sci; 2023; 128():. PubMed ID: 37441110
[TBL] [Abstract][Full Text] [Related]
28. Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care.
Mowat C; Digby J; Strachan JA; McCann RK; Carey FA; Fraser CG; Steele RJ
Ann Clin Biochem; 2021 May; 58(3):211-219. PubMed ID: 33334134
[TBL] [Abstract][Full Text] [Related]
29. Comparison with first round findings of faecal haemoglobin concentrations and clinical outcomes in the second round of a biennial faecal immunochemical test based colorectal cancer screening programme.
Clark GR; Fraser CG; Strachan JA; Steele RJ
J Med Screen; 2022 Dec; 29(4):249-254. PubMed ID: 35747907
[TBL] [Abstract][Full Text] [Related]
30. Management strategies for the colonoscopic surveillance of people with Lynch syndrome during the COVID-19 pandemic.
Monahan KJ; Lincoln A; East JE; Benton S; Burn J; DeSouza B; Hanson H; Lalloo F; McVeigh T; Rutter MD; Snape K; Thomas HJW; Sasieni P
Gut; 2021 Mar; 70(3):624-626. PubMed ID: 32571974
[No Abstract] [Full Text] [Related]
31. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.
Stinton C; Jordan M; Fraser H; Auguste P; Court R; Al-Khudairy L; Madan J; Grammatopoulos D; Taylor-Phillips S
Health Technol Assess; 2021 Jun; 25(42):1-216. PubMed ID: 34169821
[TBL] [Abstract][Full Text] [Related]
32. Impact of introducing a faecal immunochemical test (FIT) for haemoglobin into primary care on the outcome of patients with new bowel symptoms: a prospective cohort study.
Mowat C; Digby J; Strachan JA; McCann R; Hall C; Heather D; Carey F; Fraser CG; Steele RJC
BMJ Open Gastroenterol; 2019; 6(1):e000293. PubMed ID: 31275586
[TBL] [Abstract][Full Text] [Related]
33. Erratum to: Risk-stratified faecal immunochemical testing (FIT) for urgent colonoscopy in Lynch syndrome during the COVID-19 pandemic.
BJS Open; 2023 Nov; 7(6):. PubMed ID: 38029326
[No Abstract] [Full Text] [Related]
34. Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer).
Stoffel EM; Turgeon DK; Stockwell DH; Zhao L; Normolle DP; Tuck MK; Bresalier RS; Marcon NE; Baron JA; Ruffin MT; Brenner DE; Syngal S;
Cancer Prev Res (Phila); 2008 Nov; 1(6):470-5. PubMed ID: 19138994
[TBL] [Abstract][Full Text] [Related]
35. Systematic review: non-endoscopic surveillance for colorectal neoplasia in individuals with Lynch syndrome.
van Liere ELSA; de Boer NKH; Dekker E; van Leerdam ME; de Meij TGJ; Ramsoekh D
Aliment Pharmacol Ther; 2022 Apr; 55(7):778-788. PubMed ID: 35181895
[TBL] [Abstract][Full Text] [Related]
36. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
37. Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test requests.
Nicholson BD; James T; Paddon M; Justice S; Oke JL; East JE; Shine B
Aliment Pharmacol Ther; 2020 Sep; 52(6):1031-1041. PubMed ID: 32677733
[TBL] [Abstract][Full Text] [Related]
38. Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England.
Crooks CJ; Banerjea A; Jones J; Chapman C; Oliver S; West J; Humes DJ
Aliment Pharmacol Ther; 2023 Aug; 58(4):443-452. PubMed ID: 37421214
[TBL] [Abstract][Full Text] [Related]
39. One or two faecal immunochemical tests in an organised population-based colorectal cancer screening programme in Murcia (Spain).
Tourne-Garcia C; Perez-Riquelme F; Monteagudo-Piqueras O; Fraser CG; Yepes-Garcia P
J Med Screen; 2022 Dec; 29(4):231-240. PubMed ID: 35578555
[TBL] [Abstract][Full Text] [Related]
40. Colonoscopic prioritization in colorectal carcinoma screening using quantitative immunochemical faecal occult blood test: a pilot study.
Chong HY; Roslani AC; Law CW
Med J Malaysia; 2013; 68(1):30-3. PubMed ID: 23466763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
